Founded in 2019, Virtue Diagnostics is an in vitro diagnostic provider committed to platform innovation in emerging markets. We have built a management team with decades of experience in the in vitro diagnostic industry and a global vision, coupled with robust R&D, operation and commercialization capabilities. We set up our industrialization bases in China, Brazil and Indonesia, and R&D centers in Singapore, China and Brazil. We are continuously expanding our global footprint through cooperative R&D, investment, mergers and acquisitions.
Focusing on oncology and chronic diseases, Virtue Diagnostics utilizes innovative technology platforms such as clinical mass spectrometry, multiplex immunohistochemistry and molecular diagnostics to expand the China market.
Through local capabilities built in emerging countries, Virtue is providing completed diagnostics menu cross biochemistry, chemiluminescence and molecular technologies.
Company Details
- Employees
- 54
- Founded
- -
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- https://www.virtuedx.com/
- Keywords
- IVD and 体外诊断.
Virtue Diagnostics Questions
Virtue Diagnostics's website is https://www.virtuedx.com/
Virtue Diagnostics's LinkedIn profile is https://www.linkedin.com/company/virtue-diagnostics-co-ltd
Virtue Diagnostics has
54 employees.
View email and phone details for 54
employees at Virtue Diagnostics.
Virtue Diagnostics's industry is
Medical Equipment Manufacturing
Virtue Diagnostics's top competitors are
Roche,
Pt Diastika Biotekindo,
Pt. Ubc Medical Indonesia Tbk,
Pt Endo Indonesia,
Labtest Diagnóstica S.a.,
Pt Saba Indomedika,
Virtue Diagnostics Indonesia,
Abbott,
Enseval Medika Prima, Pt,
Pt Transmedic Indonesia.
Virtue Diagnostics's categories are Medical Equipment Manufacturing
Virtue Diagnostics's founding year is 2019
